United Statesmtc

Dan Mendelson, CEO of Morgan Health, highlighted the disproportionate impact of rising health insurance costs on small businesses in the U.S., citing premium increases of 20-25% as a significant challenge. He explained that cost drivers include expensive new medical technologies like GLP-1 drugs and labor costs, which constitute about 70% of hospital expenses. He speaks with Romaine Bostick & Katie Greifeld on "The Close."

Jamey Millar, Novo Nordisk's Executive Vice President of US Operations, discussed the company's preparations for the upcoming CMS bridge program, which will impact Medicare beneficiaries' access to obesity treatments. Millar highlighted uncertainty about whether patient volume will surge immediately or gradually after the program's July 1 rollout, noting ongoing efforts to educate healthcare providers and pharmacists on patient eligibility. He speaks with Romaine Bostick & Katie Greifeld on "The Close."

Insilico Medicine Founder & CEO Alex Zhavoronkov discusses how his company aims to apply artificial intelligence to revolutionize drug discovery and longevity research. He speaks with Haslinda Amin from the sidelines of 'JPMorgan Global China Summit' in Shanghai.

Dexcom CEO Jake Leach joined Bloomberg Open Interest to explain why continuous glucose monitors are becoming much bigger than diabetes devices. He says GLP-1 drugs are actually boosting CGM adoption and defends the company's growth outlook. He also lays out Dexcom's push into mainstream metabolic health and wellness.

Zepp Health (NYSE:ZEPP) reported a 43% year-over-year increase in fourth-quarter revenue, reaching $85.2 million and meeting the high end of its previous guidance.

World Health Organization Chief Tedros Adhanom Ghebreyesus speaks to Bloomberg's Mishal Husain about the US stance on mRNA vaccine research funding. "I hope they will reconsider," he says on The Mishal Husain Show. He also talks about his relationship with US Health Secretary Robert F. Kennedy Jr., saying they "continue to speak to each other."